Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume
- PMID: 28464368
- PMCID: PMC5581238
- DOI: 10.1111/jon.12444
Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume
Abstract
Background and purpose: Perform an investigation of the frequency and distribution of leptomeningeal enhancement on postgadolinium magnetization-prepared FLAIR (MPFLAIR) in multiple sclerosis (MS) on 7 Tesla (7T) MRI and to relate this finding to measures of brain structure and lesion volumes.
Methods: Twenty-nine participants with MS underwent 7T MRI of the brain. Three healthy volunteers (HVs) were scanned for comparison. Areas of postcontrast leptomeningeal enhancement were identified. Images were segmented for brain structure and lesion volumes. The relationship between leptomeningeal enhancement and clinical and volumetric data was explored.
Results: Two patterns of enhancement were found: "nodular" (discrete, spherical nodules at the pial surface or subarachnoid space) and "spread/fill" (appearance of contrast spread through the local subarachnoid space). Twenty-six of 29 (90%) MS participants had at least one focus of leptomeningeal enhancement. Nodular foci were present in 15 of 29 (51%) MS participants. Spread/fill foci were present in 22 of 29 (76%) MS participants. Two HVs had examples of nodular foci, but none had spread/fill enhancement. MS participants with spread/fill foci were older (48.9 years [SD 8.3]) than those without (33.3 years [SD 11.5], P = .005). MS participants with spread/fill foci had reduced cortical gray matter volume compared to those without (P = .020).
Conclusions: Leptomeningeal enhancement on postcontrast 7T MPFLAIR is more prevalent than prior reports at 3T-occurring at frequencies closer to histopathologic data. Spread/fill foci are associated with reduced cortical gray matter volumes and may represent blood-meningeal barrier breakdown near sites of meningeal inflammation, whereas nodular foci may be a normal variant.
Keywords: 7 Tesla; Multiple sclerosis; meningeal; meningeal enhancement; meningeal inflammation; ultra-high field MRI.
Copyright © 2017 by the American Society of Neuroimaging.
Figures




Similar articles
-
No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.Mult Scler. 2020 Feb;26(2):165-176. doi: 10.1177/1352458519876037. Epub 2019 Oct 1. Mult Scler. 2020. PMID: 31573837 Free PMC article.
-
Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.AJNR Am J Neuroradiol. 2018 Oct;39(10):1799-1805. doi: 10.3174/ajnr.A5796. Epub 2018 Sep 13. AJNR Am J Neuroradiol. 2018. PMID: 30213813 Free PMC article.
-
Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.PLoS One. 2024 May 29;19(5):e0300298. doi: 10.1371/journal.pone.0300298. eCollection 2024. PLoS One. 2024. PMID: 38809920 Free PMC article.
-
Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review.JAMA Neurol. 2017 Jan 1;74(1):100-109. doi: 10.1001/jamaneurol.2016.4237. JAMA Neurol. 2017. PMID: 27893883 Review.
-
Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging.Neuroimaging Clin N Am. 2024 Aug;34(3):453-468. doi: 10.1016/j.nic.2024.03.007. Epub 2024 May 19. Neuroimaging Clin N Am. 2024. PMID: 38942527 Free PMC article. Review.
Cited by
-
Neuroimaging to monitor worsening of multiple sclerosis: advances supported by the grant for multiple sclerosis innovation.Front Neurol. 2023 Dec 1;14:1319869. doi: 10.3389/fneur.2023.1319869. eCollection 2023. Front Neurol. 2023. PMID: 38107636 Free PMC article. Review.
-
Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple Sclerosis.J Clin Med. 2022 Jul 23;11(15):4288. doi: 10.3390/jcm11154288. J Clin Med. 2022. PMID: 35893382 Free PMC article. Review.
-
Imaging of meningeal inflammation should become part of the routine MRI protocol - Yes.Mult Scler. 2019 Mar;25(3):330-331. doi: 10.1177/1352458518794082. Epub 2018 Sep 4. Mult Scler. 2019. PMID: 30179064 Free PMC article. No abstract available.
-
The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis.Front Cell Neurosci. 2023 Feb 15;17:1101379. doi: 10.3389/fncel.2023.1101379. eCollection 2023. Front Cell Neurosci. 2023. PMID: 36874213 Free PMC article. Review.
-
Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study.J Clin Med. 2019 Mar 12;8(3):344. doi: 10.3390/jcm8030344. J Clin Med. 2019. PMID: 30870983 Free PMC article.
References
-
- Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 2011;134(Pt 9):2755–71. - PubMed
-
- Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130(Pt 4):1089–104. - PubMed
-
- Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol. 2010;68(4):477–93. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical